Skip to content

Clinical trials

Completed Heart Septal Defects, Atrial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Septal Defects, Atrial Status: Completed Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20071
20081
20091
20102
20121
20131
20142
20153
20162
20171
20183
20202
20211
20222
20231
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Carag AG3
National Heart, Lung, and Blood Institute (NHLBI)3
W.L.Gore & Associates3
Abbott Medical Devices2
Duke University2
Lifetech Scientific (Shenzhen) Co., Ltd.2
Universitaire Ziekenhuizen KU Leuven2
Aditya Kaza1
Asklepion Pharmaceuticals, LLC1
Children's Healthcare of Atlanta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Septal Defects, Atrial38
Heart Septal Defects, Ventricular10
Heart Defects, Congenital8
Foramen Ovale, Patent7
Cardiovascular Diseases4
Ductus Arteriosus, Patent4
Heart Diseases3
Hypertension, Pulmonary3
Atrial Fibrillation2
Down Syndrome2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.